A pharmaceutical composition is described for reducing weight, which comprises a mixture of Orlistat and L-carnitine, as active ingredients and a pharmaceutically acceptable vehicle. Also described is a method for producing said composition, in which the Orlistat undergoes moistening and moist granulation, which offsets problems of sticking or poor fluidity in the case or this compound.
